2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow HBV: new trials by email Literature Review of HBV trials Research Report on HBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Entecavir Extended Release (XR) in Healthy Subjects Entecavir - HBV | Phase 1 | Completed | Aucta Pharmaceuticals, Inc | 40 | 2017-10-20 | 2018-06-27 |
| A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B Single Ascending Dose (SAD) Cohorts GS-9620, Multiple Ascending Dose (MAD) Cohorts - Hepatitis B, HBV | Phase 1 | Completed | Gilead Sciences | 49 | 2012-04-01 | 2013-11-14 |
Hepatitis (1) · Hepatitis B (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Hepadnaviridae Infections (1) · Hepatitis, Viral, Human (1) · Infections (1) · Liver Diseases (1) · Virus Diseases (1)
Cohort Studies (1) · Sagittal Abdominal Diameter (1) · entecavir (1) · mycophenolic adenine dinucleotide (1)
Aucta Pharmaceuticals, Inc (1) · Gilead Sciences (1)
Australia (2) · Canada (1) · New Zealand (1) · South Korea (1) · United States (1)